NASDAQ:CDLX - Cardlytics Stock Price, Forecast & News

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

Cardlytics Inc (NASDAQ:CDLX) released its quarterly earnings results on Tuesday, November, 12th. The company reported $0.03 EPS for the quarter, topping analysts' consensus estimates of ($0.28) by $0.31. The firm earned $56.42 million during the quarter, compared to analysts' expectations of $50.02 million. Cardlytics had a negative net margin of 17.01% and a negative return on equity of 44.53%. The firm's revenue for the quarter was up 63.2% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.15) EPS. View Cardlytics' Earnings History.

Cardlytics is scheduled to release their next quarterly earnings announcement on Tuesday, March 3rd 2020. View Earnings Estimates for Cardlytics.

Cardlytics issued an update on its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $68.5-69.5 million, compared to the consensus revenue estimate of $59 million.

7 brokers have issued 12-month price targets for Cardlytics' shares. Their forecasts range from $26.00 to $100.00. On average, they anticipate Cardlytics' stock price to reach $62.00 in the next twelve months. This suggests that the stock has a possible downside of 41.1%. View Analyst Price Targets for Cardlytics.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cardlytics.

Media stories about CDLX stock have trended somewhat negative this week, InfoTrie reports. The research firm ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cardlytics earned a daily sentiment score of -1.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Cardlytics.

Some companies that are related to Cardlytics include 58.com (WUBA), Wix.Com (WIX), Stars Group (TSG), GDS (GDS), InterXion (INXN), Sabre (SABR), HUYA (HUYA), Switch (SWCH), Tripadvisor (TRIP), Medallia (MDLA), SVMK (SVMK), DouYu International (DOYU), Pluralsight (PS), Livongo Health (LVGO) and Eventbrite (EB).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include Caterpillar (CAT), Alibaba Group (BABA), Trade Desk (TTD), Paycom Software (PAYC), Range Resources (RRC), Shopify (SHOP), Store Capital (STOR), Verizon Communications (VZ), Advanced Micro Devices (AMD) and NVIDIA (NVDA).

(CDLX) raised $76 million in an initial public offering on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Cardlytics' stock is owned by a variety of of institutional and retail investors. Top institutional investors include FMR LLC (16.89%), CAS Investment Partners LLC (12.36%), Jennison Associates LLC (2.11%), Bank of New York Mellon Corp (1.93%), Bank of America Corp DE (1.69%) and Renaissance Technologies LLC (1.65%). Company insiders that own Cardlytics stock include Aimia Inc, Bryce Youngren, Clifford Sosin, David Leslie Adams, David Thomas Evans, Kirk Somers, Lynne Marie Laube, Mark A Johnson, Polaris Venture Management Co, Scott D Grimes and Tony Weisman. View Institutional Ownership Trends for Cardlytics.

CDLX stock was sold by a variety of institutional investors in the last quarter, including Polaris Venture Management Co. V L.L.C., Jennison Associates LLC, UBS Oconnor LLC, Penn Capital Management Co. Inc., Nicholas Investment Partners LP, New York State Common Retirement Fund, Goldman Sachs Group Inc. and PNC Financial Services Group Inc.. Company insiders that have sold Cardlytics company stock in the last year include Aimia Inc, Bryce Youngren, David Leslie Adams, David Thomas Evans, Kirk Somers, Lynne Marie Laube, Mark A Johnson, Polaris Venture Management Co, Scott D Grimes and Tony Weisman. View Insider Buying and Selling for Cardlytics.

CDLX stock was purchased by a variety of institutional investors in the last quarter, including CAS Investment Partners LLC, Bank of New York Mellon Corp, Victory Capital Management Inc., Renaissance Technologies LLC, Lord Abbett & CO. LLC, Victory Capital Management Inc., FMR LLC and Crawford Lake Capital Management LLC. View Insider Buying and Selling for Cardlytics.

Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CDLX stock can currently be purchased for approximately $105.25.

Cardlytics has a market capitalization of $2.40 billion and generates $150.68 million in revenue each year. The company earns $-53,040,000.00 in net income (profit) each year or ($2.14) on an earnings per share basis. View Additional Information About Cardlytics.

The official website for Cardlytics is http://www.cardlytics.com/.

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]